GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Nature Biotechnology, Springer Science and Business Media LLC
    Abstract: Subclonal reconstruction algorithms use bulk DNA sequencing data to quantify parameters of tumor evolution, allowing an assessment of how cancers initiate, progress and respond to selective pressures. We launched the ICGC–TCGA (International Cancer Genome Consortium–The Cancer Genome Atlas) DREAM Somatic Mutation Calling Tumor Heterogeneity and Evolution Challenge to benchmark existing subclonal reconstruction algorithms. This 7-year community effort used cloud computing to benchmark 31 subclonal reconstruction algorithms on 51 simulated tumors. Algorithms were scored on seven independent tasks, leading to 12,061 total runs. Algorithm choice influenced performance substantially more than tumor features but purity-adjusted read depth, copy-number state and read mappability were associated with the performance of most algorithms on most tasks. No single algorithm was a top performer for all seven tasks and existing ensemble strategies were unable to outperform the best individual methods, highlighting a key research need. All containerized methods, evaluation code and datasets are available to support further assessment of the determinants of subclonal reconstruction accuracy and development of improved methods to understand tumor evolution.
    Type of Medium: Online Resource
    ISSN: 1087-0156 , 1546-1696
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2024
    detail.hit.zdb_id: 1494943-X
    detail.hit.zdb_id: 1311932-1
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Oxford University Press (OUP) ; 2017
    In:  Nucleic Acids Research Vol. 45, No. 15 ( 2017-09-06), p. 9108-9120
    In: Nucleic Acids Research, Oxford University Press (OUP), Vol. 45, No. 15 ( 2017-09-06), p. 9108-9120
    Type of Medium: Online Resource
    ISSN: 0305-1048 , 1362-4962
    RVK:
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2017
    detail.hit.zdb_id: 186809-3
    detail.hit.zdb_id: 1472175-2
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Blood, American Society of Hematology, Vol. 120, No. 21 ( 2012-11-16), p. 3298-3298
    Abstract: Abstract 3298 The anucleate platelets play a critical role in the formation of thrombi and prevention of bleeding. While the repertoire of platelet transcripts is a reflection of the megakaryocyte at the time of platelet differentiation, post-transcriptional events are known to occur. Furthermore, a strong correlation between the expressed mRNAs and proteome has been identified. Having a complete understanding of the platelet transcriptome is important for generating insights into the genetic basis of platelet disease traits. To capture the complexity of the platelet transcriptome, we performed RNA sequencing (RNA-seq) in leukocyte-depleted platelets from 10 males, with median age of 24.5 yrs and unremarkable medical history. Their short and long RNA platelet transcriptomes were analyzed on the SOLiD 5500xl sequencing platform. We generated ∼3.5 billion sequence reads ∼40% of which could be mapped uniquely to the human genome. Our analysis revealed that ∼9,000 distinct protein-coding mRNAs and ∼800 microRNAs (miRNAs) were present in the transcriptome of each of the 10 sequenced individuals. Comparison of the levels of mRNA expression across the 10 individuals showed an exceptional level of consistency with pair-wise Pearson correlation values ≥0.98. The miRNA expression profiles across the 10 individuals showed a similar consistency with pair-wise Pearson correlation values ≥0.98. Surprisingly, we found that these mRNAs and miRNAs accounted for a little over 1/2 of all of the uniquely mapped sequence reads suggesting the abundant presence of additional non-protein coding RNA (ncRNA) transcripts. Using the annotated entries of the latest release of the ENSEMBL database, we investigated the genetic make-up of these other transcripts. We found that ∼25% of each individual's uniquely mapped reads corresponded to non-protein coding transcripts from mRNA-coding loci. These reads accounted for more than 10,000 distinct such transcripts. In addition, each of the individuals in our cohort expressed an average of ∼1,500 pseudogenes and ∼200 long intergenic non-coding RNAs (lincRNAs). The short RNA profiles of the ten individuals revealed an abundance of diverse categories of ncRNAs including the signal recognition particle RNA (srpRNA), small nuclear RNA (snRNA) and small cytoplasmic RNAs (scRNA). These ncRNAs are involved in the processing of pre-mRNAs and their presence and prevalence in the anucleate platetet suggests the existence of a complex network of mRNA processing that persists after the megakaryocyte fragmentation. We also investigated the RNA-omes of the ten individuals for evidence of transcription of the pyknon category of ncRNAs. Pyknons are of particular interest because each has numerous intergenic and intronic copies whereas nearly all known human protein-coding genes contain one or more pyknons in their mRNA. Recent experimental work has shown that intergenic instances of the pyknons are transcribed in a tissue- and cell-state specific manner. An average of ∼100,000 pyknons are transcribed in each of the 10 sequenced individuals suggesting the possibility of a far-reaching network of interactions that link exonic space to distant non-exonic regions and are active in platelets. Lastly, we found that a large variety of distinct repeat element categories are expressed in the RNA-omes (both short and long) of these individuals. Among the most abundantly represented categories of repeat elements were DNA transposons, long terminal repeat (LTR) retrotransposons, and non-LTR retrotransposons such as long interspersed elements (LINEs) and short interspersed elements (SINEs). In summary, our RNA-seq analyses have revealed a spectrum of platelet transcripts that transcends protein-coding genes and miRNAs. Indeed, the transcripts that have their source in genomic features not previously discussed or analyzed in the platelet context represent a very significant portion of all platelet transcripts. This in turn suggests an unanticipated richness, and presumably commensurate complexity, for the platelet transcriptome. While the role of these novel non-protein coding RNAs is currently unknown it is expected that at least some of them may be of functional significance which will in turn permit a better understanding of the molecular mechanisms that regulate platelet physiology and may contribute to processes beyond thrombosis and hemostasis. Disclosures: No relevant conflicts of interest to declare.
    Type of Medium: Online Resource
    ISSN: 0006-4971 , 1528-0020
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Hematology
    Publication Date: 2012
    detail.hit.zdb_id: 1468538-3
    detail.hit.zdb_id: 80069-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 77, No. 13_Supplement ( 2017-07-01), p. 4423-4423
    Abstract: Background: RNA-seq is the new standard for profiling coding and non-coding RNAs in a cell. This study compared two methods for miRNA library preparation from NEB and Qiagen. Our goal was to evaluate overall performance in terms of coverage, known miRNA detection, novel miRNA detection, isomiR detection, and tRNA fragment (tRF) detection. Methods: We performed short RNA-seq on 4 lung cancer tumor-normal pairs. We used two library preparation kits: NEB Next Small RNA kit and Qiagen Qiaseq. All 16 preparations were sequenced on an Illumina NextSeq 550 using NextSeq High V2 chemistry and 75 bp single-end reads were obtained. After adapter removal and quality trimming reads were mapped to the hg19 human genome assembly using the Bowtie2 and SHRiMP packages. Results: On average read yield was 46 million reads. A significantly higher portion of the sequenced reads survived adapter removal and quality trimming in the NEB preparations (96.5%) compared to the Qiagen (72.9%). The portion that could be uniquely mapped to hg19 was lower for the NEB kit (41.1%) than for the Qiagen (50.8%).NEB performed better (39.6%) compared with Qiagen (36.9%). Qiagen preparations had lengths between 20 and 25 bp whereas more than half of the mapped reads in the NEB preparation were 26 bp or longer. At the miRNA arm level the Qiagen kit detected significantly more known miRNAs (792) with 10 or more reads, compared with NEB (576). The same 530 miRNA arms were identified by both kits. There was no discernible pattern in the ID’s or the sequence composition of the miRNAs that were identified by each kit. The detection of novel miRNAs was also higher with Qiagen (102), compared with NEB (82). The same 79 novel miRNAs were identified by both. The Qiagen kit detected nearly twice as many isomiRs (5,316) with 10 or more reads compared to NEB (2,958). The same 2,631 isomiRs were identified by both kits. However, isomiR detection across samples was more consistent with the NEB kit. When we computed pairwise Pearson correlations of normal samples, using the most highly expressed miRNAs in each sample, the NEB kit exhibited higher consistency (0.98) compared with the Qiagen kit (0.95). Pearson correlations of tumor samples showed even higher consistency for NEB (0.96) than Qiagen (0.89). Unsurprisingly, Pearson correlations of like samples across the NEB and Qiagen kits was very low: 0.42 for normal and 0.56 for tumor samples. RIN value did not seem to affect the overall performance of either kit. Lastly, we compared tRFs. Here, the differences were very pronounced. For multiple choices of the support threshold the NEB and Qiagen profiles agreed on approximately 33% of the reported tRFs. Conclusions: Library preparation kits give rise to both consistent and divergent results. End users interested in the detection of miRNAs, isomiRs or tRFs may derive greater utility by selecting one kit over another. Citation Format: Brid M. Ryan, Phillipe Loher, Khadijah Mitchell, Adriana Zingone, Yongmei Zhao, Jyoti Shetty, Bao Tran, Isidore Rigoutsos. Deep sequencing of lung cancer samples using different library preparation methods produces discordant short non-coding RNA profiles [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4423. doi:10.1158/1538-7445.AM2017-4423
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2017
    In:  Cancer Epidemiology, Biomarkers & Prevention Vol. 26, No. 2_Supplement ( 2017-02-01), p. B43-B43
    In: Cancer Epidemiology, Biomarkers & Prevention, American Association for Cancer Research (AACR), Vol. 26, No. 2_Supplement ( 2017-02-01), p. B43-B43
    Abstract: We define transcriptomic heterogeneity (TH) as the phenomenon wherein “the same exact segment of DNA produces different RNA products either in different tissues of the same individual, or in the same tissue of individuals who differ in one or more variables such as sex, population origin, race, age, etc.” In TH, the disease state is associated with differences in the RNA molecules that are produced from a given segment of DNA. This differs from genomic heterogeneity wherein one associates a disease state with variations and polymorphisms in the DNA template itself. We have shown that TH is relevant to the study of race disparities in breast and prostate cancers, and implicated two classes of non-coding RNAs (ncRNAs): microRNAs and transfer RNAs. Next, we describe our findings separately for each class. MicroRNAs (miRNAs) are a well-known class of powerful regulators that control the abundance of messenger RNAs (mRNAs), and, thus, of proteins, in animals and plants. MiRNA studies long assumed that each arm of the miRNA precursor produced at most one consequential mature miRNA. Rapidly emerging data have now revealed a complex picture whereby a given miRNA precursor arm simultaneously produces a cloud of isoforms, the isomiRs, with 5´ and 3´ endpoints that differ slightly from one another's. Emerging findings suggest that isomiRs represent a fundamental paradigm shift in how to study the roles of miRNAs in cancer and force us to reconsider the conventional view of “one-miRNA-precursor-arm-one-product.” Firstly, isomiRs are known to enter the RNA interference (RNAi) pathway and thus have functional roles in regulating transcript and protein abundance. Secondly, we showed that in healthy individuals and cancer patients, the identities and abundances of the isomiRs produced by a miRNA genomic locus depend on a person's race, sex, and population origin and also on tissue type, disease subtype, and possibly other variables. Thirdly, using BT-20 and MDA-MB-468, two cell lines modeling triple negative breast cancer (TNBC) in White (Wh) and Black or African American (B/Aa) patients respectively, we demonstrated that distinct isomiRs from the same miRNA locus can target largely non-overlapping groups of mRNAs. Fourthly, using the same two cell lines (BT-20 and MDA-MB-468) we showed that the impact on proliferation by a given isomiR differs by race. Transfer RNAs (tRNAs) were discovered sixty years ago. tRNAs are present in all three kingdoms of life. The conventional understanding had been that the genomic loci encoding tRNAs produce a precursor transcript which is processed to give rise to the mature tRNA used in codon translation. As was the case with miRNAs, the analysis of deep sequencing data revealed that tRNA fragments, known as tRFs, are produced from the full-length premature or mature tRNAs. We carried out parallel investigations of the profiles of tRFs across hundreds of healthy individuals and cancer patients and were able to generate several key results. Firstly, we showed that tRFs are produced constitutively in healthy people and in cancer patients. Secondly, we showed that the identities and abundances of the tRFs produced by a tRNA genomic locus depend on a person's race, sex, and population origin and also on tissue type, disease subtype, and possibly other variables. Thirdly, we showed that tRFs from the same tRNA alter the expression of largely non-overlapping groups of mRNAs. Fourthly, we showed that the impact on proliferation by a given tRF differs by race. Our findings show that isomiRs and tRFs are newly discovered important regulators whose roles depend on a patient's race. These currently uncharacterized molecules need to be taken into account in studies of race-based cancer disparities. Citation Format: Isidore Rigoutsos, Aristeidis G. Telonis, Phillipe Loher, Rogan Magee, Yi Jing, Eric Londin. Transcriptomic Heterogeneity of microRNA Isoforms and tRNA Fragments contributes to Race-based Differences in Breast and Prostate Cancers. [abstract]. In: Proceedings of the Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2016 Sep 25-28; Fort Lauderdale, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2017;26(2 Suppl):Abstract nr B43.
    Type of Medium: Online Resource
    ISSN: 1055-9965 , 1538-7755
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036781-8
    detail.hit.zdb_id: 1153420-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2018
    In:  Cancer Epidemiology, Biomarkers & Prevention Vol. 27, No. 7_Supplement ( 2018-07-01), p. B64-B64
    In: Cancer Epidemiology, Biomarkers & Prevention, American Association for Cancer Research (AACR), Vol. 27, No. 7_Supplement ( 2018-07-01), p. B64-B64
    Abstract: Prostate cancer is the most frequently occurring cancer in men. Compared to White (Wh) men, Black/African American (B/Aa) men exhibit higher mortality and higher incidence rates of prostate cancer. This difference remains even after modifiable factors are taken into account, which suggests an underlying cause. Recent studies greatly improved our understanding of the biochemistry of prostate cancer. Nonetheless, many open questions remain, especially with regard to the molecular underpinnings of the observed race disparities. In this study, we analyzed 526 transcriptomic datasets from prostate adenocarcinoma (PRAD) patients. We obtained the data from The Cancer Genome Atlas (TCGA) repository. We focused on two categories of noncoding RNAs that regulate messenger RNA (mRNA) and protein abundance: (1) microRNAs (miRNAs) and their isoforms (isomiRs) and (2) tRNA-derived fragments (tRFs). Both tRFs and isomiRs regulate mRNAs and their proteins through the RNA induced silencing complex (RISC). Furthermore, tRFs have a number of other regulatory roles in healthy and diseased cells, including direct physical interactions with ribosomal proteins and initiation factors. Notably, we have demonstrated and reported previously that isomiRs and tRFs are constitutive and transcribed in a manner that depends strongly on a person's gender, race, and population origin, as well as on tissue type, tissue state, and disease type/subtype. Our analyses of the TCGA PRAD datasets revealed that both isomiRs and tRFs are disrupted in PRAD. By extension, the regulatory networks that link isomiRs and tRFs to mRNAs are also disrupted. We also uncovered transcriptomic differences and differential regulatory relationships that are aligned with patient race. Moreover, we found that the molecular differences between B/Aa and Wh PRAD patients extend to normal prostate tissue as well. These findings mirror earlier results that we obtained from both healthy individuals and cancer patients. The race-dependent regulatory profiles highlight differences in the underlying biology in B/Aa and Wh individuals that have yet to be explored. For example, the corresponding molecules could potentially be leveraged as novel biomarkers or alternative therapeutic targets. This study represents the first characterization of isomiRs and tRFs in a large cohort of PRAD patients. Citation Format: Rogan G. Magee, Aristeidis G. Telonis, Phillipe Loher, Eric Londin, Isidore Rigoutsos. Race and prostate cancer: miRNA isoforms and tRNA fragments could hold some of the answers [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr B64.
    Type of Medium: Online Resource
    ISSN: 1055-9965 , 1538-7755
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2018
    detail.hit.zdb_id: 2036781-8
    detail.hit.zdb_id: 1153420-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2015
    In:  Cancer Research Vol. 75, No. 15_Supplement ( 2015-08-01), p. 231-231
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 15_Supplement ( 2015-08-01), p. 231-231
    Abstract: Background: MicroRNAs (miRNAs) are short non­coding RNAs that are key post­transcriptional regulators of transcript abundance. During the last decade, their dysregulation has been linked to many human cancers and other human conditions. Similarly to messenger RNAs miRNAs have isoforms (“isomiRs”). In terms of abundance, one of the isomiRs from a given locus typically dominates. In terms of sequence, any two isomiRs from the same locus typically differ by 2-3 nucleotides (nts) at either the 5′ end, the 3′ end, or both. We recently reported on the isomiR profiles (“isomiR-omes”) of lymphoblastoid cell lines (LCLs) derived from ∼500 healthy individuals. We found that each miRNA locus gives rise to multiple isomiRs; often, the most abundant isoform was not the one listed in the miRBase database. Importantly, we demonstrated that many isomiRs exhibited gender-dependent expression whereas other isomiRs exhibited population-dependent or race-dependent expression. Are isomiRs prevalent in the cancer context? And if so, are they relevant? Methods: We analyzed deep sequencing data obtained from healthy and diseased tissues seeking to characterize in each case the respective isomiR-ome by studying all transcribed miRNA loci. The datasets were obtained from The Cancer Genome Atlas (TCGA) repository and included short RNA profiles from breast cancer (BRCA) and other cancers. To investigate isomiR-ome differences between various subsets among the samples we used multivariate statistical analyses. Results: The isomiR-ome differences that we observed in our analyses of LCLs prompted us to extend the analyses to the disease context. Indeed, such isomiR differences can potentially lead to post­transcriptional regulation differences by altering the set of targeted transcripts, especially since isomiRs can differ in their 5´ end. We first analyzed the BRCA TCGA datasets and identified hundreds of distinct and abundant isomiRs. In several instances, a miRNA locus generated between five and ten significantly expressed isomiRs the most abundant of which generally did not match the representative miRBase sequence. Notably, we found that isomiR abundance profiles could distinguish among BRCA subtypes. Also importantly, several isomiRs showed differential expression across racial boundaries. Preliminary analyses of other TCGA cancer datasets led to similar results. Conclusions: Our findings reveal that miRNA isoforms are present and abundant in cancer tissues and differentially expressed among cancer sub-types. This suggests that isomiRs likely play significant roles in the cancer context. Their omni-presence and characteristic expression profiles also suggest that they should be taken into account when studying the miRNA-mediated post-transcriptional regulation layer of cancers. Lastly, our findings also suggest possible uses for isomiRs as molecules for cancer therapeutic and diagnostic purposes. Citation Format: Eric R. Londin, Phillipe Loher, Aristeidis Telonis, Isidore Rigoutsos. MicroRNA isoforms come of age: Going beyond the one-locus-one-microRNA paradigm in cancer biology. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 231. doi:10.1158/1538-7445.AM2015-231
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2015
    In:  Cancer Research Vol. 75, No. 13_Supplement ( 2015-07-01), p. A34-A34
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 13_Supplement ( 2015-07-01), p. A34-A34
    Abstract: Pancreatic ductal adenocarcinoma (PDAC) is currently the 4th leading cause of cancer related deaths in the U.S. and expected to become the 2nd leading cause behind only lung cancer over the next decade. MicroRNAs (miRNAs) are short non-coding RNAs, with a length of ~22 nucleotides (nts), that play key roles in post-transcriptional gene regulation. Their dysregulation has been implicated in many cancers including PDAC. Alternative processing of miRNA precursors can result in the formation of isomiRs that differ by a few bps in either the 5′ and/or 3′ ends of the miRNAs. These seemingly slight differences can potentially alter the set of genes that are targeted by a particular miRNAs thereby resulting in differences in the post-transcriptional regulation program. To examine the role of isomiRs in PDAC, we performed next-generation sequencing of the short RNA transcriptome in two pancreatic cell lines, HPNE and MIA PaCa-2. Using next-generation sequencing. Over 1,000 isomiRs, arising from 500 distinct miRNA loci, were identified as being statistically significantly expressed in the cell lines. Of these isomiRs, we identified over 200 that were differentially expressed between the HPNE and MIA PaCa-2 cell lines. Interestingly, 44 miRNA loci gave rise to a differentially expressed isomiR that differed from the one currently listed in miRBase v.20. This suggests that distinct isomiRs from the same miRNA locus can exhibit differences in their expression patterns. In addition to being expressed in the HPNE and MIA PaCa-2 cell lines, we were able to confirm the presence of many of these isomiRs in the short RNA sequences of PDAC primary tissues from The Cancer Genome Atlas (TCGA) project. To further explore the functional role of these isomiRs, we sought potential targets for them among the deep-sequenced data that we obtained from the HPNE and MIA PaCa-2 cell lines after UV-crosslinking followed by Immunoprecipitation with the Argonaute antibody (Ago-CLIP-seq). Indeed, we find that isomiRs from similar miRNA loci do exhibit differences in their preferences for mRNA targets. Furthermore, Gene Ontology (GO) analysis of the genes targeted by isomiRs reveals an enrichment for pathways involved in the regulation of cell death in the HPNE cell lines. Analogously, isomiR targets in the MiaPaCa-2 cell lines exhibit an enrichment for cell motility pathways. In summary, we find that isomiRs of specific miRNA loci exhibit differences in their expression levels, have distinct mRNA target preferences in two model cell lines, and are specifically involved in the post-transcriptional events regulating gene expression. Citation Format: Eric R. Londin, Phillipe Loher, Kevin Quann, Kathleen Delgrosso, Paolo Fortina, Jonathan Brody, Isidore Rigoutsos. Regulation of pancreatic cells by isomiRs. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Innovations in Research and Treatment; May 18-21, 2014; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2015;75(13 Suppl):Abstract nr A34.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2016
    In:  Cancer Research Vol. 76, No. 6_Supplement ( 2016-03-15), p. A46-A46
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 76, No. 6_Supplement ( 2016-03-15), p. A46-A46
    Abstract: Transcriptome profiling using next generation sequencing has revealed the existence of many RNA species that do not code for proteins and are differentially abundant between normal and tumor. Despite great advances in elucidating their roles in the cell, the vast majority of these non-coding RNAs (ncRNAs) remain to be functionalized. Through several recent studies, we found that the populations of transcriptional products from many human ncRNA loci are far more dynamic than currently believed. Specifically, we have discovered that the human genome loci that harbor microRNAs (mIRNAs) and transfer RNAs (tRNAs) respectively produce a multitude of constitutive, previously unsuspected transcripts that differ between normal and tumor and whose composition and abundance depend on several variables that include a patient's gender, population, and race. Such patient attributes will thus need to be considered explicitly in studies of post-transcriptional regulatory programs in cancer. The conventional view holds that miRNA precursors produce at most one consequential mature miRNA from each arm of the precursor hairpin. In the public repositories, each of the known genomic miRNA loci is represented by at most two such sequences, one per arm. We refer to this representative product of a hairpin arm as the arm's “archetype” miRNA. The increasing numbers of transcriptomic datasets have uncovered a different reality wherein each miRNA precursor arm produces multiple isoforms (the “isomiRs”) of the archetype miRNA. These isomiRs enter the RNA interference pathway just like the archetype miRNA sequences and have sequence-dependent downstream regulatory effects. By analyzing transcriptomic data from the 1,000 Genome Project (1KG) and from The Cancer Genome Atlas (TCGA), we found that the production of isomIRs from a miRNA locus is marshaled and depends on a person's gender, population, and race. IsomiR production from a miRNA locus also depends on the tissue under consideration and on disease type/subtype. Moreover, co-expressed isomiRs from the same miRNA locus are generally not well-correlated. Lastly, in a cancer model cell line, we over-expressed isoforms of a miRNA with race-depended abundance in TCGA data: we found that these isoforms had targetomes that had little overlap even though they originated from the same miRNA locus. tRNAs have long been considered to serve as adaptor molecules with well-defined roles in the translation of messenger RNA (mRNA) into amino acid sequences. In recent years, this view is starting to change. Key to the renewed attention to tRNAs has been the discovery of tRNA fragments (tRFs), which are produced in parallel to the mature tRNAs that are used in translation. Increasing numbers of reports have been linking tRFs to cell growth, cell proliferation, response to DNA damage, translation initiation, response to stress, etc. and have shown that some tRFs are loaded on Argonaute and thus enter the RNAi pathway. Our analyses of data from the 1KG and the TCGA projects have revealed that nuclear and mitochondrial tRNAs produce a multitude of tRFs with variable, yet quantized, lengths. We found that, in complete analogy to isomiRs, the tRFs are constitutive in nature, exhibit composition and abundance that differ across tissues and between normal and tumor samples, and depend on a person's gender, population, and race. We also discovered a novel and very rich category of tRFs, the internal-tRFs or i-tRFs: i-tRFs have variable quantized lengths, and variable starting and ending points that are wholly contained within the span of the mature tRNA. Of note, i-tRFs contribute much of the difference that we observe across the gender, population, race, tissue, and disease subtype boundaries. Lastly, using fragment-specific approaches, we were able to validate several i-tRFs in clinical samples and in model cell lines. Citation Format: Isidore Rigoutsos, Aristeidis Telonis, Phillipe Loher, Eric Londin. Tissue biology is shaped by noncoding RNAs that depend on gender, population, and race. [abstract]. In: Proceedings of the AACR Special Conference on Noncoding RNAs and Cancer: Mechanisms to Medicines ; 2015 Dec 4-7; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2016;76(6 Suppl):Abstract nr A46.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2016
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2016
    In:  Cancer Epidemiology, Biomarkers & Prevention Vol. 25, No. 3_Supplement ( 2016-03-01), p. PR04-PR04
    In: Cancer Epidemiology, Biomarkers & Prevention, American Association for Cancer Research (AACR), Vol. 25, No. 3_Supplement ( 2016-03-01), p. PR04-PR04
    Abstract: Noncoding RNAs (ncRNAs) are molecules that do not code for proteins but regulate cell physiology via multiple mechanisms. Through studies of hundreds of human datasets from healthy individuals and patients we found for two categories of ncRNAs that their composition and abundances depend on a person's gender, population, race, and several other variables. These two categories are: a) isoforms of microRNAs (miRNAs), also known as isomiRs; and, b) fragments derived from transfer RNAs (tRNAs), also known as tRNA fragments or tRFs. Traditionally, a miRNA genomic locus was thought to give rise to a single mature miRNA (archetype). The archetype's sequence was recorded in public databases and used to design reagents and experiments. Advances in sequencing technology have revealed that miRNA loci simultaneously give rise to multiple isomiRs, i.e. isoforms of the archetype miRNAs, with distinct endpoints and abundances. Importantly, isoforms are loaded on the RNA-induced silencing complex (RISC) thereby entering the RNA interference (RNAi) pathway where they guide sequence-based RISC interactions with specifically targeted messenger RNAs (mRNAs) and ncRNAs, thusly controlling the abundance of those transcripts. Moreover, miRNAs have been linked to a multitude of cellular processes in health and disease. Analogously, the genomic loci harboring tRNAs were thought to give rise to only the mature tRNA sequence, the latter being an integral part of the translation of mRNAs into amino acid sequences. As with isomiRs, modern sequencing technology revealed the existence of tRNA fragments that co-exist with the corresponding full-length mature tRNAs. Fast accumulating evidence has already linked tRFs to cell growth, cell proliferation, response to DNA damage, translation initiation, response to stress, etc. Some tRFs have also been found on RISC and to participate in RNAi, similarly to isomiRs. We investigated isomiRs and tRFs in human samples, in health and disease. Specifically, we used public transcriptomic datasets from the 1,000 Genomes Project and from The Cancer Genome Atlas (TCGA) repository at the National Institutes of Health. By analyzing samples from nearly five hundred healthy individuals we found that both the isomiR profiles and the tRF profiles depend on a person's gender, population, race, tissue and tissue state. In the case of tRNA fragments, we found that they derive from nuclear and from mitochondrial tRNAs. By focusing on data from cancer patients we found that the dependencies we uncovered extend to the disease context as well. In particular, our analysis of samples from White and African-American triple negative breast cancer (TNBC) patients showed that there exist extensive and significant differences in the isomiR and tRF profiles between the two races. More specifically, we identified many isomiRs and tRFs that are differentially abundant in TNBC samples from White patients vs. TNBC samples from African-American patients. We also found that analogous isomiR and tRF differences distinguish the normal breast samples of White and African American subjects. When we integrated the isomiR information with mRNA expression values from the corresponding TCGA TNBC samples we found that the molecular biology differences in the isomiR and tRF profiles were indeed reflected in the abundance of protein coding genes, a result that could serve as a starting point for deeper research activities towards explaining health disparities in this breast cancer subtype. Our studies suggest that miRNA isoforms and tRNA fragments are active novel members of the molecular biology of TNBC. Future studies of this disease will need to also consider these molecules given that they represent a component of the cell's regulatory layer that depends on the patient's race. This abstract is also presented as Poster C62. Citation Format: Aristeidis G. Telonis, Phillipe Loher, Yi Jing, Eric Londin, Isidore Rigoutsos. The molecular biology of nuclear and mitochondrial regulatory noncoding RNAs differs between white and African American patients with triple-negative breast cancer. [abstract]. In: Proceedings of the Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Nov 13-16, 2015; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2016;25(3 Suppl):Abstract nr PR04.
    Type of Medium: Online Resource
    ISSN: 1055-9965 , 1538-7755
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2016
    detail.hit.zdb_id: 2036781-8
    detail.hit.zdb_id: 1153420-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...